Press Releases
Search
-
16 Dec 2020
bioMérieux announces the CE marking of its molecular biology ARGENE® test for the simultaneous detection of SARS-CoV-2, influenza viruses A and B, and RSV and hMPV viruses
Marcy l’Etoile, France – December 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the real-time PCR (RT-PCR) detection ...
-
14 Dec 2020
Increased outlook for full-year 2020
Marcy l'Étoile, December 14, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, today released its adjusted outlook for full-year 2020.
-
14 Dec 2020
The French bioproduction sector announces the creation of Campus Biotech Digital, a platform unique in the world for bioproduction training
An ambitious goal to develop the skills necessary for health independence...
-
02 Dec 2020
BIOASTER, Université de Technologie de Compiègne, Hospices Civils de Lyon and bioMérieux formalize strategic collaboration to conduct Next Generation Sequencing technology evaluation in microbiology
Lyon, December 2, 2020 - BIOASTER Microbiology Technology Research Institute announced a strategic partnership in the field of sequencing-based diagnostics in microbiology with the Université de Techn...
-
16 Nov 2020
bioMérieux announces the expansion of the CE marking of its molecular biology ARGENE® SARS-CoV-2 diagnostic test to include saliva specimens.
Marcy l’Etoile, France – November 16, 2020 – bioMérieux, a world leader in the field of in vitro diagnostics, has announced the expansion of its ARGENE® range for the detection of SARS-CoV-2. As a com...
-
22 Oct 2020
bioMérieux – Information financière du 3e trimestre 2020
Croissance organique de 19,4 % à taux de change et périmètre constants au terme des 9 premiers mois : 2 266 millions d’euros de chiffre d’affaires +17,5 % de croissance à données publiées Poursuite de...
-
22 Oct 2020
bioMérieux – Third-Quarter 2020 Business Review
Organic growth of 19.4% at constant exchange rates and scope of consolidation over the first nine months of the year: €2,266 million in sales Up 17.5% as reported Further exceptional momentum in the t...
-
08 Oct 2020
AMSP partners with bioMérieux to facilitate supply of high-quality COVID-19 diagnostics
bioMérieux and the Africa Medical Supplies Platform (AMSP), have announced a new partnership to facilitate the supply of high-quality diagnostic solutions from the bioMérieux Pandemic Response Portfol...
-
02 Sep 2020
First-Half 2020 Results
Organic sales growth of 15.7% in first-half 2020: €1,476 million in sales Up 15.8% as reported As expected, a mixed sales performance, with faster momentum in molecular biology solutions contrasting w...
-
16 Jul 2020
Launch of BIOFIRE® MYCOPLASMA test for mycoplasma detection in biopharmaceutical products
bioMérieux, a world leader in the field of in vitro diagnostics, has announced the launch of BIOFIRE® MYCOPLASMA, an innovative test for mycoplasma detection in pharmaceutical products used for biothe...
-
09 Jul 2020
Second-Quarter 2020 Business Performance Preannouncement
In light of the withdrawal of its annual objectives, bioMérieux, a world leader in the field of in vitro diagnostics, today announced preliminary quarterly information about its business activity endi...
-
29 Jun 2020
bioMérieux issues a €200 million Euro PP bond
Marcy l’Étoile (France) - June 29, 2020 – bioMérieux, a global leader in the field of in vitro diagnostics, announces that it has successfully issued today a €200 million Euro PP new debt with a top-t...
-
15 Jun 2020
BIOFIRE® Respiratory Panel 2.1 plus with SARS-CoV-2 is CE marked
bioMérieux, a world leader in the field of in vitro diagnostics, today announced that the BIOFIRE® Respiratory Panel 2.1 plus (RP2.1plus) is CE marked. The BIOFIRE® Respiratory Panel 2.1 plus (RP2.1pl...
-
21 May 2020
CE marking of bioMérieux serology tests for SARS-CoV-2 on VIDAS®
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the CE marking of VIDAS® anti-SARS-CoV-2 serology tests to detect antibodies in people who have been exposed to SARS-Co...
-
19 May 2020
Information concerning 2019 dividend and the bioMérieux General Shareholders’ Meeting
The Board of Directors of bioMérieux met today and decided to hold the annual General Shareholders’ Meeting behind closed doors at the bioMérieux registered office on June 30, 2020. During this meetin...